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The influence of the characteristics of ischemic
tissue lesions on ulcer healing time after
infrainguinal bypass for critical leg ischemia
Maria Söderström, MD, Pekka-Sakari Aho, MD, PhD, Mauri Lepäntalo, MD, PhD, and
Anders Albäck, MD, PhD, Helsinki, Finland
Objective: Ulcer healing is a seldom reported outcome in studies of critical leg ischemia (CLI). The aim of this study was
to analyze local factors affecting ulcer healing time after infrainguinal bypass surgery (IBS) for CLI Fontaine IV.
Methods: In this prospective single center cohort study, 110 patients (113 legs) undergoing IBS due to CLI with ischemic
tissue defects during year 2006 were followed prospectively for 1 year after the bypass. Ulcer location, duration, presence
of gangrene, and the University of Texas wound classification (UTWCS) were determined at presentation. Healing time
of the ischemic tissue defects, leg salvage, patency, and survival were calculated. The characteristics of the ischemic tissue
lesions and patient comorbidities were analyzed to determine risk factors for adverse outcome.
Results: Complete ulcer healing (SE) was achieved in 74%  5% of the legs 12 months after IBS. Median ulcer healing
time was 186 days (range, 11 to >365 days). Leg salvage, secondary patency, and survival at 12 months were 87%  3%,
82%  4%, and 76%  5%, respectively. Amputation-free survival with healed ulcers was attained in 55% at 12 months.
Ischemic tissue lesions located in the mid- and hindfoot had significantly prolonged ulcer healing time (hazard ratio [HR]
0.4, 95% confidence interval [CI] 0.1 to 0.9, P  .044). None of the UTWCS classes predicted either ulcer healing time
or leg salvage. Median ulcer duration before IBS was 68 days, range, 6 to 1154 days. Ulcer duration did not correlate with
ulcer healing time (Spearman r  0.138, P  .267). Ischemic ulcers with gangrene were not associated with prolonged
ulcer healing time (P  .353).
Conclusion: The location of the ischemic tissue lesions influences ulcer healing time. According to our study UTWCS can
be used as descriptive classification of ischemic ulcers but it does not predict the ulcer healing time or leg salvage after
infrainguinal bypass surgery. (J Vasc Surg 2009;49:932-7.)The success of infrainguinal bypass surgery (IBS) for
critical leg ischemia (CLI) has traditionally been measured
in terms of graft patency, leg salvage, and mortality without
distinguishing Fontaine II and IV lesions.1 The Trans-
Atlantic Conference on Clinical Trial Guidelines in Periph-
eral Arterial Occlusive Disease recommended complete
ulcer healing of both legs as a primary endpoint for the
treatment of CLI Fontaine stage IV.1,2 Healing rate of the
ischemic tissue lesions is an important but seldom reported
event. A recent literature research (1985-2005) identified
1915 papers on revascularization in CLI, but ulcer healing
after bypass surgery was reported only in six studies.3
Reported healing rates of ischemic tissue lesions 12 months
after IBS vary between 70% and 88%.4-8 Previous studies
have shown that diabetes is associated with prolonged ulcer
healing time.8-10 End stage renal disease have been sug-
gested to interfere with ulcer healing11 and increase the risk
of major amputation and death.8,12
University of Texas wound classification system
(UTWCS), among health care providers, is an increasingly
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932used wound classification system, which assesses ulcer
depth, presence of infection in the ulcer, and presence of
clinical signs of lower-extremity ischemia.13 UTWCS has
been shown to predict wound healing even better14 than
the formally used Wagner classification.15 The aim of this
study was to analyze how lesion characteristics according to
UTWCS (stage and grade) affect ulcer healing time and leg
salvage. We also wanted to analyze if the location of the
ischemic tissue defect, the presence of gangrene in the
ischemic lesion, and the duration of the ischemic ulcer
correlate with ulcer healing time and leg salvage.
MATERIAL AND METHODS
Ethical aspects. The study protocol was approved by
the Institutional Review Board of Helsinki University Cen-
tral Hospital (Department of Surgery), decision number
158/year 2006.
Patients. All patients undergoing infrainguinal bypass
surgery due to critical leg ischemia with tissue loss (CLI
Fontaine IV)2 during year 2006 in Helsinki University
Central Hospital (HUCH) were included in this prospec-
tive study. The study cohort consisted of 110 patients with
113 critical ischemic legs. Fifty-eight were males (51%) and
55 females aged 43 to 97 years, median age 75 years. Three
patients with bilateral disease had bilateral reconstructions.
All patients had objectively verified peripheral arterial dis-
ease16 with infrainguinal arterial occlusions too long to be
treated endovascularly. Comorbidities were common; Half
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heart disease (Table I). All patients had been ambulant
before IBS.
Ischemic tissue lesion. The information about the
duration of the ischemic tissue defects was obtained from
the referral or by asking the patient or a proxy. Ulcer
duration was defined as the period between the date when
the presence of the ischemic tissue lesion was noticed and
the date of IBS. At the time of the bypass operation, the
surgeon classified the ischemic tissue lesion according to
UTWCS13 and registered the location of the lesion and
presence of gangrene. In case of multiple ischemic tissue
lesions, the grade was classified according to the lesion with
the highest grade. The ischemic tissue lesion was classified
infected if at least one of the lesions was infected (Table II).
None of the ulcers were stage A (noninfected nonischemic)
or stage B (infected nonischemic). The ischemic tissue
defect was located on the forefoot in 71 legs (63%), on the
mid- and hindfoot area in 13 legs (12%), and in the crural
area in 24 legs (21%). Five legs (4%) had ischemic tissue
defects in multiple regions. 47 legs (42%) had ulcers with
gangrene and 66 legs had ischemic ulcers without gan-
grene.
Median preoperative ankle-brachial index (ABI) was
0.43, range, 0-1.69. Median toe pressure was 20 mm Hg,
Table I. Patient comorbidities
Condition N (%)
BMI  25 38 (34.5)
Cerebrovascular disease 24 (21.8)
Chronic pulmonary disease 16 (14.5)
Coronary artery disease 73 (66.3)
Diabetes mellitus 55 (50)
ESRD necessitating dialysis 8 (7.3)
Hyperlipidemia 50 (45.5)
Hypertension 84 (76.4)
BMI, Body mass index (kg/m2); ESRD, end stage renal disease.
The information about the comorbidities was extracted from the Husvasc
vascular registry with recheck from patients’ case records.
Table II. Description of the ischemic tissue defects of
the 113 legs according to University of Texas wound
classification system (UTWCS)
U T W C S
n %Grade Stage
1 C 41 36.3
1 D 19 16.8
2 C 10 8.8
2 D 10 8.8
3 C 10 8.8
3 D 23 20.4
Grade 1, superficial ulcer; Grade 2, ulcer penetrating to tendon or joint
capsule; Grade 3, ulcer penetrating into joint or bone; Stage C, noninfected
ischemic ulcer; Stage D, infected ischemic ulcer.ranging from 0 to 40 mm Hg.Vascular reconstruction. All patients underwent pre-
operative angiography to evaluate the extent of arterial
occlusions and to choose appropriate inflow and outflow
vessels. Twelve reconstructions (11%) were redo proce-
dures. Common femoral artery was selected most fre-
quently as inflow site for proximal anastomosis whereas the
most common outflow artery of the bypass was the dorsal
pedal artery (Table III). Vein grafts were used in 99 infrain-
guinal reconstructions (88%); 14 had prosthetic grafts.
Nonreversed translocated saphenous grafts were used most
frequently.
Adjunctive treatments. All patients received routine
peroperatively intravenous antibiotics according to the bac-
teria culture from the ischemic ulcer or if no culture was
available cefuroxime was administered intravenously. If a
prosthetic graft was used the patients received also intrave-
nous vancomycin. Postoperative per oral antibiotic regimen
was chosen according to the bacteria culture. However,
when local ulcer surgery was performed the corresponding
antibiotics were given intravenously. Diabetic patients re-
ceived antibiotics as long as their ulcers healed. Even non-
diabetic patients received antibiotics postoperatively for 1
month or longer if there were signs of infection in the tissue
lesions. A total number of 105 local operations on 57 legs
(50%) were performed to treat the ischemic tissue lesions,
between one and six local ulcer operations per leg; 50
minor amputations (range, 1-2), 35 revisions (range, 1-2),
and 20 split thickness skin graftings (range, 1-2).
Surveillance. Follow-up visits in the vascular outpa-
tient clinic were at 1 month (range, 3 weeks to 2 months),
6 months (range, 5-7 months), and 12 months (range,
11-13 months) after the bypass surgery according to our
routine graft surveillance program. Follow-up included
clinical status of the foot, duplex ultrasound of the graft,
toe pressure measurements, and ABI. Local wound care
was chosen depending on the characters of each lesion.
When necessary, further interventions for failing grafts or
ulcers were performed. The mean number of follow-up
Table III. Details of the 113 infrainguinal bypasses
performed to treat CLI with tissue loss (Fontaine IV)
Artery N (%)
Inflow
Common femoral artery 72 (63.7)
Deep femoral artery 3 (2.7)
Superficial femoral artery 19 (16.8)
Proximal popliteal artery 6 (5.3)
Distal popliteal artery 13 (11.5)
Outflow
Proximal popliteal artery 19 (16.8)
Distal popliteal artery 22 (19.5)
Tibioperoneal trunk 3 (2.7)
Anterior tibial artery 20 (17.7)
Posterior tibial artery 12 (10.6)
Peroneal artery 13 (11.5)
Dorsal pedal artery 23 (20.4)
Plantar artery 1 (0.9)visits at the outpatient clinic during the first postoperative
hrou
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out the wound care.
We defined ulcer healing time as the time from the IBS
to the date when the ischemic tissue defects present at the
time of the bypass operation were completely epithelial-
ized. Healing time of the incisional wounds was not in-
cluded in the calculations.
For this study, follow-up terminated 1 year after the
infrainguinal bypass operation or at the time of major
amputation or death. If there was still a non-healed tissue
lesion in the leg 1 month before death, the patient was
considered to die with a nonhealed ulcer. Major amputa-
tions were considered as nonhealed tissue lesions.
Data collection. Data on preoperative characteristics,
risk factors, surgical details, and postoperative outcomes
were prospectively added into our local vascular registry
Husvasc within the course of each patients care. Informa-
tion about the wound healing process was also collected
from the office chart database, which covers the entire
university hospital district. Survival data were gathered
from the Population Register Center.
Statistical analysis. Data were processed using the
SPSS 15.0 statistical software package (SPSS Inc., Chicago,
Ill). The relationship between the duration of the ischemic
and ulcer healing time as well as the duration of the
ischemic ulcer and leg salvage were analyzed by calculating
the Spearman rank correlation coefficient. Ulcer healing
time, leg salvage, survival, and patency rates were calculated
using the Kaplan-Maier method (univariate analysis). Cox
regression analysis provided risk ratios of clinically relevant
Fig 1. Kaplan-Meier curve demonstrating healing time
bypass surgery. The standard errors were less than 10% tfactors for ulcer healing time and major amputation (mul-tivariate analysis). Differences between groups were consid-
ered statistically significant if the P values were  .05.
RESULTS
Eight patients (4%) were lost to follow-up before reach-
ing any of the study endpoints or ulcer healing.
Survival. The cumulative survival rate ( standard
error, [SE]) at 12 months was 76% 4%. The amputation-
free survival rate (SE) was 72%  4% at 12 months.
Amputation-free survival with healed ulcers was attained in
55% of the patients at 12 months.
Patency. The overall primary patency, assisted primary
patency and secondary patency17 rates (SE) at 12 months
after IBS were 74%  6%, 80%  6%, and 82%  5%,
respectively. Median ABI was 0.92 (range, 0.30-1.68) and
median toe pressure 64 mm Hg (range, 0-130 mm Hg) 6
months postoperatively.
Ulcer healing time. Ulcer healing rate (SE) was
26% 5% at 3 months, 47% 5% at 6 months, and 74%
5% at 12 months (Fig 1). The median time to complete
ulcer healing was 186 days (range, 11 days to 365 days).
Ischemic tissue lesions located in themid- and hindfoot
had significantly prolonged ulcer healing time (hazard ratio
[HR] 0.4, 95% confidence interval [CI] 0.1 to 0.9, P 
.044) (Fig 2). None of the UTWCS classes had a predictive
effect on ulcer healing time in the Cox regression analysis
(Table IV). Ulcer healing time did not increase with in-
creasing grade. The healing rate of stage C ulcers appeared
higher at one year after IBS compared with stageD ulcers in
the Kaplan-Meier test but the difference was not statistically
e ischemic tissue defects in 113 legs after infrainguinal
ghout the time interval analyzed (range, 0-5 %).of thsignificant (76% vs 67%, P  .575). Diabetes was the only
%.
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univariate (P  .036) and multivariate analysis (HR 0.6,
95% CI 0.4 to 0.9, P .05) (Table V). At 12 months after
the IBS, the ulcer healing rates in diabetics and nondiabet-
ics were 65% and 79%, respectively. Among diabetics, no
UTWCS class had a predictive effect in the Cox regression
analysis on ulcer healing time. Ulcers with gangrene were
not associated with prolonged ulcer healing time compared
with ischemic ulcers without gangrene (Kaplan-Meier test,
P  .353). Univariate analysis showed no difference in the
ulcer healing time between patients who had local ulcer
surgery and patients who had not local ulcer surgery (P 
.968). Revision of the graft did not influence ulcer healing
Fig 2. Healing times of ischemic tissue defects after infra
Asterisk (*) indicates that the standard error was over 10
Table IV. Cox regression analysis did not show any
relationship between the University of Texas wound
classification system (UTWCS) classes and ulcer healing
time after IBS for CLI. Non-infected superficial ischemic
ulcer (1C) was the reference class
U T W C S
Multivariate analysis
HR (95% CI) P value
1 C 1.0 .559
1 D 1.1 (0.5-2.3) .754
2 C 0.5 (0.2-1.4) .193
2 D 0.6 (0.3-1.5 .291
3 C 1.3 (0.6-3.0) .535
3 D 0.9 (0.4-1.7) .669
HR, Hazard ratio; CI, confidence interval.time (Kaplan-Meier test, P  .162) while graft occlusionpredicted prolonged ulcer healing time (Kaplan-Meier test,
P  .008). Median ulcer duration before IBS was 68 days,
range, 6 to 1154 days. No correlation was found between
ulcer duration and ulcer healing time (Spearman r 0.138,
P  .267), (Fig 3).
Leg salvage. The overall cumulative leg salvage rate
(SE) at 12 months was 87%  3%. Fourteen major
amputations were performed during the first postoperative
year. All major amputations were due to a progressing
nonhealing ischemic ulcer; two legs had a concomitant
inal bypass surgery according to different ulcer locations.
Table V. Uni- and multivariate analysis of factors related
to ulcer healing time in 113 legs after infrainguinal bypass






P value HR (95% CI) P value
BMI  25 .320 0.5 (0.3-1.1) .080
Cerebrovascular disease .243 0.4 (0.2-1.1) .085
Chronic pulmonary disease .397 1.1 (0.4-3.1) .784
Coronary artery disease .728 1.4 (0.7-2.7) .318
Diabetes mellitus .036 0.6 (0.4-0.9) .050
Hyperlipidemia .752 1.8 (0.6-6.3) .312
Hypertension .342 1.0 (0.4-2.2) .918
ESRD with dialysis .195 0.4 (0.1-4.0) .462
HR,Hazard ratio; CI, confidence interval; BMI, body mass index (kg/m2);
ESRD, end stage renal disease.
aKaplan-Meier method.
bCox regression.inguhealing problem in the incisional wound. Half of the major
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major amputations were performed to legs with ischemic
tissue lesions in themid- and hindfoot but the result did not
reach statistical significance (HR 2.2, 95% CI 0.7 to 7.3,
P .165). None of theUTWCS classes predicted increased
risk for major amputation. Neither grade nor stage alone
predicted significantly increased risk for major amputation.
Ulcers with gangrene were not associated with poor leg
salvage compared with ischemic ulcers without gangrene
(Kaplan-Meier analysis, P  .813). There was not a corre-
lation between ulcer duration and leg salvage (Spearman r
 0.116, P  .240). Of the comorbidities end stage renal
disease necessitating dialysis (ESRD) (HR 11, 95% CI 3.9
to 36, P .001) and coronary artery disease (HR 5.7, 95%
CI 1.2 to 26, P .022) turned out to significantly increase
the risk of major amputation in multivariate analysis.
DISCUSSION
Ulcer healing is a slow process despite a successful
revascularization. Less than half of the patients achieved
complete ulcer healing within half year after IBS. However,
the ulcer healing time in our study may be overestimated
because the status of the tissue lesion was not checked every
month. In the study by Chung, the median ulcer healing
time was even longer.4
We recognize that our study has limitations. The time
period during which the patients were collected restricted
the number of patients included in the study. The number
of legs in each subgroup was not predictable due to the
prospective nature of our study. Due to the small number
of patients, the study might lack power to adequately
analyze the differences between subgroups. Our results can
be compared only with few studies because published pro-
Fig 3. Scatterplot demonstrating the duration of the i
healing time of the ischemic tissue lesions after IBS. The
time (Spearman r  0.138, P  .267).spective ulcer healing studies in CLI are sparse.The prolonged healing time for ischemic tissue defects
located in mid- and hindfoot area could be explained by
factors on the background of lesions located in the heel,
such as poor general condition requiring bed rest. Ischemic
tissue lesions located in the heel area have also earlier been
associated with poor leg salvage.18
Ischemic ulcers with gangrene were not associated with
prolonged ulcer healing time. In this study, we did not
analyze the size of the ischemic tissue lesion. Tukiainen
et al18 noted that large tissue defects predict poor leg
salvage.
We did not note a predictive effect of the different
UTWCS classes on either ulcer healing time or leg salvage.
The outcome did not significantly deteriorate with increas-
ing stage or grade. Deep lesions healed equally well as
superficial lesions, and we did not note differences between
the healing times of infected and noninfected lesions. This
could be explained by the fact that most of the patients with
lesions penetrating to bone or lesions classified infected
were treated by a minor amputation or surgical revision.
The assessment of the grade of the ischemic ulcer appeared
difficult especially if the lesion was covered by a dry fibrous
eschar not necessitating debridement. Oyibo et al14 noted
that stage but not grade had predictive effect on ulcer
healing time in diabetics. Armstrong et al19 reported that
diabetic patients with ulcer infection were at higher risk for
amputation than those without infection and those patients
with ulcers penetrating to bone were more likely to receive
a midfoot or higher level amputation. The fact that our
study included only ischemic feet and every patient had a
revascularization may explain the differences in the results
in this study compared with the studies of Oyibo and
ic ulcer before infrainguinal bypass surgery (IBS) and
no correlation between ulcer duration and ulcer healingschem
wasArmstrong.14,19 The inability to demonstrate a significant
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small sample size in our study.
Diabetes turned out to be the only comorbidity, which
significantly delayed ulcer healing time. The small number of
patients with ESRD did not allow valid subgroup analysis.
The duration of the ischemic tissue lesion did not play
a significant role in determining either ulcer healing time or
leg salvage in our study. Our result is in line with the study
byMätzke,20 which showed that the duration of symptoms
indicating CLI does not play a significant role in determin-
ing risk for major amputation. Chung et al4 reported that
the duration of CLI-symptoms correlated with prolonged
ulcer healing time. Chung et al4 included healing times of
subsequent amputation incisions whereas we considered
major amputations as nonhealed ulcers. The ulcer duration
reported might be affected by patient-related bias. Elderly
patients might not remember when they noticed the isch-
emic tissue lesion. For patients with neuropathy it may take
time to realize the existence of a tissue lesion. An explana-
tion for the lack of correlation between ulcer duration and
ulcer healing time as well as leg salvage could be the
differences in severity of ischemia. The degree of ischemia
might influence the progression of the ulcer.
CONCLUSION
Ulcers located in themid- and hindfoot were associated
with prolonged ulcer healing time. According to our study,
UTWCS can be used as descriptive classification of ischemic
ulcers, but it does not predict the ulcer healing time or leg
salvage. This study may indicate a need for a different
classification for ischemic ulcers that includes the location
of the tissue lesion.
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